Investor Presentaiton slide image

Investor Presentaiton

IMPACT 1. Background □ Very high disease burden EVALUATION ■ Estimated 57.5 million cases and 225,000 deaths (25% of global malaria burden; WHO 2008) ■ 11% of maternal and 29% of under five death is due to malaria Low effective LLIN coverage (use of net) ■ Under Five 3.5% and Pregnant Women 3.2% (though recent mass distribution has probably improved this; Roll Back Malaria 2007) □ Low coverage of ACTS, first-line drug ■ Coverage skewed to urban areas (Oladepo et al. 2007) ■ 2.3% of anti-malarials sold are ACTS (ACTWatch 2008) 2
View entire presentation